BamSEC and AlphaSense Join Forces
Learn More

Nektar Therapeutics

NASDAQ: NKTR    
Share price (9/29/25): $58.92    
Market cap (9/29/25): $1.121 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 8-K 1 page Certificate of Amendment to the Amended Certificate of Incorporation of Nektar Therapeutics
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended Certificate of Incorporation of Nektar Therapeutics
12/34/56
EX-3.1
from 8-K 26 pages Corporate Seal
12/34/56
EX-3.1
from 8-K 23 pages Corporate Seal
12/34/56
EX-3.1
from 8-K 25 pages Corporate Seal
12/34/56
EX-3.1
from 8-K 35 pages Corporate Seal
12/34/56
EX-3.1
from 8-K 24 pages Corporate Seal
12/34/56
EX-3.6
from 10-Q 2 pages Certificate of Elimination of Nektar Therapeutics Pursuant to Section 151(g) of the Delaware General Corporation Law
12/34/56
EX-3.5
from 10-Q 2 pages Certificate of Elimination of Nektar Therapeutics Pursuant to Section 151(g) of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 23 pages Amended and Restated Bylaws of Nektar Therapeutics
12/34/56
EX-3.6
from 10-K 8 pages Certificate of Ownership and Merger of Nektar Therapeutics Al, Corporation, an Alabama Corporation, With and Into Nektar Therapeutics a Delaware Corporation (Signature Page Follows) 1
12/34/56
EX-3.1
from 8-K 20 pages Amended and Restated Bylaws of Nektar Therapeutics
12/34/56
EX-3.1
from 8-K 6 pages Certificate of Ownership and Merger Merging Nektar Merger Sub, Inc. With and Into Inhale Therapeutic Systems, Inc. Pursuant to Section 253 of the Delaware General Corporation Law
12/34/56
EX-3.5
from 8-K ~5 pages Certificate of Designation of Series B Convertible Preferred Stock of Inhale Therapeutic Systems, Inc
12/34/56
EX-3.3
from 10-Q 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3.2
from 10-Q ~20 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 10-Q ~5 pages Articles of Incorporation or Bylaws
12/34/56